Search Results - "Dagnew AF"

Design and feasibility considerations for a phase 3 efficacy trial of the M72/AS01E-4 tuberculosis vaccine.

Authors: Dagnew AF Noble R Cinar A et al.

Source: Vaccine [Vaccine] 2026 Jul 11; Vol. 85, pp. 128690. Date of Electronic Publication: 2026 May 12.

Publication Type: Clinical Trial Protocol; Journal Article

Journal Info: Publisher: Elsevier Science Country of Publication: Netherlands NLM ID: 8406899 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1873-2518 (Electronic) Linking ISSN: 0264410X NLM ISO Abbreviation: Vaccine Subsets: MEDLINE

Turkish Society for Rheumatology 2026 vaccine recommendations for adult rheumatology patients.

Alternate Title: Türkiye Romatoloji Derneği 2026 erişkin romatoloji hastalarında aşı önerileri.

Authors: İlbay, Ahmet Uslu, Emine Sezer, Serdar et al.

Source: Journal of Turkish Society for Rheumatology. 2026, Vol. 18 Issue 2, p150-166. 17p.

A modular nanoparticle display strategy for varicella-zoster virus gE based on a licensed protein scaffold.

Authors: Xue, Wenhui Wang, Hong Zeng, Yarong et al.

Source: PLoS Pathogens. 3/2/2026, Vol. 22 Issue 3, p1-20. 20p.

The role of interferon-gamma release assays in tuberculosis vaccine trials: strengths, limitations, and implications beyond trial design.

Authors: Dagnew AF Schmidt AC Cinar A et al.

Source: Vaccine [Vaccine] 2026 Jun 10; Vol. 88, pp. 128822. Date of Electronic Publication: 2026 Jun 10.

Publication Type: Journal Article

Journal Info: Publisher: Elsevier Science Country of Publication: Netherlands NLM ID: 8406899 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1873-2518 (Electronic) Linking ISSN: 0264410X NLM ISO Abbreviation: Vaccine Subsets: MEDLINE

Group-based trajectory modeling to describe the geographical distribution of tuberculosis notifications.

Authors: Dagnew AF Hanrahan CF Dowdy DW et al.

Source: BMC public health [BMC Public Health] 2025 Feb 27; Vol. 25 (1), pp. 797. Date of Electronic Publication: 2025 Feb 27.

Publication Type: Journal Article

Journal Info: Publisher: BioMed Central Country of Publication: England NLM ID: 100968562 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2458 (Electronic) Linking ISSN: 14712458 NLM ISO Abbreviation: BMC Public Health Subsets: MEDLINE

A promising endeavor against human cytomegalovirus: Predominant epitopes-based recombinant subunit vaccine RHEc^{IE1/pp65/pp150}.

Authors: Li, Zonghui Jiang, Shasha Liu, Wenxuan et al.

Source: Virulence. Dec2025, Vol. 16 Issue 1, p1-19. 19p.

Implications of subclinical tuberculosis for vaccine trial design and global effect.

Authors: Churchyard GJ Houben RMGJ Fielding K et al.

Source: The Lancet. Microbe [Lancet Microbe] 2024 Oct; Vol. 5 (10), pp. 100895. Date of Electronic Publication: 2024 Jul 01.

Publication Type: Journal Article; Review; Research Support, Non-U.S. Gov't

Journal Info: Publisher: Elsevier Ltd Country of Publication: England NLM ID: 101769019 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2666-5247 (Electronic) Linking ISSN: 26665247 NLM ISO Abbreviation: Lancet Microbe Subsets: MEDLINE

Global burden of vaccine‐associated rheumatic diseases and their related vaccines, 1967–2023: A comprehensive analysis of the international pharmacovigilance database.

Authors: Oh, Jiyeon Jo, Hyesu Park, Jaeyu et al.

Source: International Journal of Rheumatic Diseases. Aug2024, Vol. 27 Issue 8, p1-11. 11p.

Preparing for Tuberculosis Vaccine M72/AS01E Implementation: A Global Demand Forecast and Key Influential Factors.

Authors: Kallenberg, Judith Milea, Dominique Breuer, Thomas et al.

Source: Infectious Diseases & Therapy. May2026, Vol. 15 Issue 5, p1263-1279. 17p.

Tuberculin skin test and Interferon-gamma release assay agreement, and associated factors with latent tuberculosis infection, in medical and nursing students in Bandung, Indonesia.

Authors: Apriani, Lika McAllister, Susan Sharples, Katrina et al.

Source: PLoS ONE. 3/18/2024, Vol. 19 Issue 3, p1-10. 10p.

The Potential Impact of Increased Recombinant Zoster Vaccine Uptake in Older Adults Worldwide.

Authors: Giannelos, Nikolaos Curran, Desmond Matthews, Sean et al.

Source: Infectious Diseases & Therapy. Jun2025, Vol. 14 Issue 6, p1327-1341. 15p.

Pathogen Distribution and Antimicrobial Resistance of Early Onset Sepsis in Very Premature Infants: A Real-World Study.

Authors: Ji, Hongyan Yu, Yonghui Huang, Lei et al.

Source: Infectious Diseases & Therapy. Oct2022, Vol. 11 Issue 5, p1935-1947. 13p.

End-point definition and trial design to advance tuberculosis vaccine development.

Authors: Garcia-Basteiro AL White RG Tait D et al.

Source: European respiratory review : an official journal of the European Respiratory Society [Eur Respir Rev] 2022 Jun 07; Vol. 31 (164). Date of Electronic Publication: 2022 Jun 07 (Print Publication: 2022).

Publication Type: Journal Article; Review

Journal Info: Publisher: European Respiratory Society Country of Publication: England NLM ID: 9111391 Publication Model: Electronic-Print Cited Medium: Internet ISSN: 1600-0617 (Electronic) Linking ISSN: 09059180 NLM ISO Abbreviation: Eur Respir Rev Subsets: MEDLINE

Effect of herpes zoster vaccine on patients after hematopoietic stem cell transplantation: a systematic review and meta-analysis.

Authors: Jiao, Xunyi Zhu, Jinli Ding, Yangyang et al.

Source: Virology Journal. 3/2/2025, Vol. 22 Issue 1, p1-10. 10p.

Cellular response to COVID-19 vaccines in hematologic malignancies patients: a new hope for non-responders?

Authors: Saad Albichr, Imane De Greef, Julien Van Den Neste, Eric et al.

Source: Leukemia & Lymphoma. Mar2022, Vol. 63 Issue 3, p743-746. 4p.

Vaccination strategies for patients with lymphoma treated in early lines of therapies: a real-world practice survey among Fondazione Italiana Linfomi centers.

Authors: Annibali, Ombretta Merli, Michele Minoia, Carla et al.

Source: Leukemia & Lymphoma. Jan2025, Vol. 66 Issue 1, p109-114. 6p.

Systematic review and meta-analysis of recombinant herpes zoster vaccine in immunocompromised populations.

Authors: Marra, Fawziah Yip, Michael Cragg, Jacquelyn J. et al.

Source: PLoS ONE. 11/25/2024, Vol. 19 Issue 11, p1-20. 20p.

Data-driven epidemiologic approach to conducting site feasibility for a global phase III tuberculosis vaccine clinical trial.

Authors: Mui WL Parekh FK Tseng AS et al.

Source: PLOS global public health [PLOS Glob Public Health] 2023 Nov 08; Vol. 3 (11), pp. e0002544. Date of Electronic Publication: 2023 Nov 08 (Print Publication: 2023).

Publication Type: Journal Article

Journal Info: Publisher: Public Library of Science Country of Publication: United States NLM ID: 9918283779606676 Publication Model: eCollection Cited Medium: Internet ISSN: 2767-3375 (Electronic) Linking ISSN: 27673375 NLM ISO Abbreviation: PLOS Glob Public Health Subsets: PubMed not MEDLINE

Vaccin contre le zona : quelles sont les données ?

Alternate Title: Shingles vaccine: what are the data?

Authors: Bergua, Gérard Le Noc, Yves Dumoulin, Marc et al.

Source: Médecine. mar2024, Vol. 20 Issue 3, p115-118. 4p.

Estimation of country-level incidence of early-onset invasive Group B Streptococcus disease in infants using Bayesian methods.

Authors: Gonçalves, Bronner P. Procter, Simon R. Clifford, Sam et al.

Source: PLoS Computational Biology. 6/14/2021, Vol. 17 Issue 6, p1-15. 15p. 1 Chart, 5 Graphs.